Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06578728 · ClinicalTrials.gov registry record · Phase 4
Local Methotrexate Injections for the Treatment of Nail Psoriasis
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT06578728 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 1 participants.
The verdict
NCT06578728, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The investigators hope to learn the efficacy of methotrexate injections for treatment of nail psoriasis.
Interventions
- DRUG Saline
- DRUG Methotrexate
- DRUG Triamcinolone Acetonide 10mg/mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2026-06-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06578728
The ClinicalTrials.gov registry entry for NCT06578728 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Saline is the first listed.
NCT06578728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06578728 about?
NCT06578728 is a clinical study titled "Local Methotrexate Injections for the Treatment of Nail Psoriasis". The investigators hope to learn the efficacy of methotrexate injections for treatment of nail psoriasis.
What is the current status of trial NCT06578728?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2025-09-10. Estimated completion is 2026-06-05.
What interventions are being tested in trial NCT06578728?
The interventions under investigation include: Saline (DRUG), Methotrexate (DRUG), Triamcinolone Acetonide 10mg/mL (DRUG).
Who is sponsoring clinical trial NCT06578728?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.